Charles River Laboratories International (CRL) Change in Acquisitions & Divestments (2009 - 2026)
Charles River Laboratories International (CRL) posted Change in Acquisitions & Divestments of $8.1 million for Q2 2026, up 178.47% on a QoQ basis from $2.9 million in Q1 2026, and up 1514.48% year-over-year from $504000.0 in Q2 2025.
Analysis
Charles River Laboratories International (CRL) Change in Acquisitions & Divestments (2009 - 2026) Analysis & Trends
Charles River Laboratories International has reported Change in Acquisitions & Divestments for 18 years, with the latest figure at $8.1 million in Q2 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 1514.48% year-over-year to $8.1 million in Q2 2026; TTM through Jun 2026 was $18.1 million, a 42.56% decrease from a year earlier, with the FY2025 full-year figure at $9.1 million, down 78.17% from the prior year.
- Change in Acquisitions & Divestments was $8.1 million for Q2 2026 at Charles River Laboratories International, up from $2.9 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $27.1 million in Q3 2024, with the low at $205000.0 in Q1 2022.
- Average Change in Acquisitions & Divestments over 5 years is $4.3 million, with a median of $2.7 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments jumped 2584.26% in 2024, then slumped 89.62% in 2025.
- Over 5 years, Change in Acquisitions & Divestments stood at $1.4 million in 2022, then surged by 87.82% to $2.7 million in 2023, then retreated by 18.31% to $2.2 million in 2024, then jumped by 56.29% to $3.5 million in 2025, then soared by 134.83% to $8.1 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $8.1 million (Q2 2026), $2.9 million (Q1 2026), and $3.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 8.14 Mn |
| Mar 28, 2026 | 2.92 Mn |
| Dec 27, 2025 | 3.47 Mn |
| Sep 27, 2025 | 3.53 Mn |
| Jun 28, 2025 | 504,000.00 |
| Mar 29, 2025 | 1.60 Mn |
| Dec 28, 2024 | 2.22 Mn |
| Sep 28, 2024 | 27.11 Mn |
| Jun 29, 2024 | 4.86 Mn |
| Mar 30, 2024 | 7.50 Mn |
| Dec 30, 2023 | 2.71 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jul 1, 2023 | 990,000.00 |
| Apr 1, 2023 | 1.95 Mn |
| Dec 31, 2022 | 1.45 Mn |
| Sep 24, 2022 | 2.90 Mn |
| Mar 26, 2022 | 205,000.00 |
| Dec 25, 2021 | 572,000.00 |
| Sep 25, 2021 | 756,000.00 |
| Jun 26, 2021 | 5.20 Mn |